Acknowledgments
The authors thank technicians in the Associated Medical Sciences Clinical Service Center, Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand for their help and assistance.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Fucharoen S, Winichagoon P. Hemoglobinopathies in Southeast Asia. Hemoglobin 1987;11:65–88.10.3109/03630268709036587Search in Google Scholar PubMed
2. Winichagoon P, Fucharoen S, Wilairat P, Fukumaki Y. Molecular mechanisms of thalassemia in southeast Asia. Southeast Asian J Trop Med Public Health 1995;26(Suppl 1):235–40.Search in Google Scholar
3. Chamras U, Sukunthamala K, Pornprasert S. SYTO9 and SYBR GREEN1 with high resolution melting analysis for molecular confirmatory testing of the common Southeast Asian beta(0)-thalassemia mutations. Hemoglobin 2009;33:539–45.10.3109/03630260903336560Search in Google Scholar PubMed
4. Galanello R, Barella S, Ideo A, Gasperini D, Rosatelli C, Paderi L, et al. Genotype of subjects with borderline hemoglobin A2 levels: implication for beta-thalassemia carrier screening. Am J Hematol 1994;46:79–81.10.1002/ajh.2830460204Search in Google Scholar PubMed
5. Giambona A, Passarello C, Vinciguerra M, Li Muli R, Teresi P, Anza M, et al. Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia. Haematologica 2008;93:1380–4.10.3324/haematol.12840Search in Google Scholar PubMed
6. Pornprasert S, Phusua A, Suanta S, Saetung R, Sanguansermsri T. Detection of alpha-thalassemia-1 Southeast Asian type using real-time gap-PCR with SYBR Green1 and high resolution melting analysis. Eur J Haematol 2008;80:510–4.10.1111/j.1600-0609.2008.01055.xSearch in Google Scholar PubMed
7. Lou JW, Li DZ, Zhang Y, He Y, Sun MN, Ye WL, et al. Delineation of the molecular basis of borderline hemoglobin A2 in Chinese individuals. Blood Cells Mol Dis 2014;53:261–4.10.1016/j.bcmd.2014.04.005Search in Google Scholar PubMed
8. Yamsri S, Singha K, Prajantasen T, Taweenan W, Fucharoen G, Sanchaisuriya K, et al. A large cohort of beta(+)-thalassemia in Thailand: molecular, hematological and diagnostic considerations. Blood Cells Mol Dis 2015;54:164–9.10.1016/j.bcmd.2014.11.008Search in Google Scholar PubMed
9. Bhagat P, Kaur Sachdeva R, Sharma P, Updesh Singh Sachdeva M, Chhabra S, Sharma A, et al. Effect of antiretroviral therapy on hemoglobin A2 values can have implications in antenatal beta-thalassemia screening programs. Infect Dis (Lond) 2016;48: 122–6.10.3109/23744235.2015.1089592Search in Google Scholar PubMed
10. Paglietti ME, Satta S, Sollaino MC, Barella S, Ventrella A, Desogus MF, et al. The problem of borderline hemoglobin A2 levels in the screening for beta-thalassemia carriers in Sardinia. Acta Haematol 2016;135:193–9.10.1159/000442194Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
